Boom of a clinical trials industry after 2020

The global COVID-19 clinical trials market size is valued at 5.0 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2021 to 2027. Boom of a clinical trials industry after 2020 .The market is majorly driven by the rapid spread of coronavirus leading to a staggering number of deaths globally thus putting pressure on healthcare organizations to provide therapeutics/vaccines. The increasing research activities on a global scale are also creating demand for COVID-19 clinical trials, boosting the market growth. Factors such as globalization of clinical trials, demand for CROs to conduct trials and technological evolution, are further anticipated to drive growth. As per the World Health Organization (WHO), till June 24th, 2020, the virus had infected around 9.1 million people globally and had claimed more than 0.47 million lives with 80% cases in the U.S. and Europe overtaking China where the pandemic first began in December 2019. The U.S., Brazil, Russia, India, and the U.K. are the five most affected countries by the pandemic. For more details contact Quetzal International College of Skill Development  or mail us at https://qicsd.com